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Abbreviations 
EV – extracellular vesicle 
NEJ – newly excysted juvenile 
HDM – helminth defence molecule 
CB – cathepsin B 
CL – cathepsin L 
LAP – leucine aminopeptidase 
Prx – peroxiredoxin 
FaBP – fatty acid-binding protein 
GST – glutathione transferase 
MVB – multivesicular body 
ESCRT – endosomal sorting complex required for transport 
DAMP - damage-associated molecular pattern 
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Summary 
Extracellular vesicles (EVs) released by parasites have important roles in establishing and 
maintaining infection. Analysis of the soluble and vesicular secretions of adult Fasciola 
hepatica has established a definitive characterisation of the total secretome of this zoonotic 
parasite. Fasciola secretes at least two sub-populations of EVs that differ according to size, 
cargo molecules and site of release from the parasite. The larger EVs are released from the 
specialised cells that line the parasite gastrodermus and contain the zymogen of the 37 kDa 
cathepsin L peptidase that performs a digestive function. The smaller exosome-like vesicle 
population originate from multivesicular bodies within the tegumental syncytium and carry 
many previously described immunomodulatory molecules that could be delivered into host 
cells. By integrating our proteomics data with recently available transcriptomic datasets we 
have detailed the pathways involved with EV biogenesis in F. hepatica and propose that the 
small exosome biogenesis occurs via ESCRT-dependent MVB formation in the tegumental 
syncytium before being shed from the apical plasma membrane. Furthermore, we found that 
the molecular “machinery” required for EV biogenesis is constitutively expressed across the 
intra-mammalian development stages of the parasite. By contrast, the cargo molecules 
packaged within the EVs are developmentally regulated, most likely to facilitate the parasites 
migration through host tissue and to counteract host immune attack. 
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Introduction 
The trematode parasite, Fasciola hepatica is the causative agent of liver fluke disease 
(fasciolosis) in domestic animals. F. hepatica infects more than 300 million cattle and 250 
million sheep worldwide resulting in losses of over $3 billion to global agriculture through 
lost productivity (1). Fasciolosis is also an important zoonotic disease with an estimated 2.6 
million people infected worldwide; human infection is particularly highly prevalent in Egypt 
and the Andes of South America, while outbreaks regularly occur in Northern Iran (2).   
Infection in animals and humans can last many years while adult parasites reside in 
the bile ducts. F. hepatica are obligate blood feeders and obtain blood by puncturing the bile 
duct wall. The regular regurgitation of parasite gut contents is thought to inject molecules 
into the bloodstream where they can exert an immunosuppressive activity on the host 
immune system (3). Other molecules are secreted from the gut, excretory pores and surface 
tegument into the bile where they may be carried to the exterior via the host intestine (4-6). 
We, and others, have previously used proteomic techniques to profile the secretome of adult 
F. hepatica (7-10) but these studies had a number of limitations: 1) they relied on very 
limited transcriptome datasets with considerable redundancy; 2) since genome sequence data 
was lacking it was not possible to determine precisely the identity and/or the number of the 
genes contributing to various secreted protein families; 3) the contribution of extracellular 
vesicles to fluke secretions was not investigated. However, our recent report of the Fasciola 
genome and associated transcriptome datasets (11) has now allowed us to address these 
limitations and perform a definitive characterisation of the total secretome of adult F. 
hepatica. This is timely given the report of exosome-like EVs released by adult F. hepatica 
(12).  
Extracellular vesicles (EVs) are small membrane bound organelles that are shed by 
most cell types. Although once considered to be “cellular garbage cans” with the sole purpose 
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of discarding unwanted cellular material (13), EVs are now recognised as important 
mediators of inter-cellular communication by transferring molecular signals, including 
proteins, lipids, mRNA, microRNA and other non-coding RNA species (14,15). Variously 
described as exosomes or microvesicles depending on their cellular origin and mode of 
biogenesis, EVs perform a variety of roles in the maintenance of normal physiology such as 
blood coagulation, immune regulation and tissue repair (16-18), but also participate in 
pathological settings, notably in tumour progression (19). A number of recent studies have 
shown that parasite-derived EVs play an important role during infection. For instance, EVs 
released by the helminth parasites Heligmosomoides polygyrus and Schistosoma japonicum 
are capable of modulating the response of host innate immune cells (20,21).   
Here, we report the deep analysis of the soluble and vesicular components of the adult 
F. hepatica secretome. We found that F. hepatica secretes at least two sub-populations of 
EVs that differ according to size, cargo molecules and potential site of release from the 
parasite. Using a proteomic approach, integrated with newly available F. hepatica genome 
and transcriptome resources (11), we have defined the protein composition of these two 
classes of vesicle and non-vesicle associated proteins. The larger 15K EVs are released from 
the specialised cells that line the parasite gastrodermus and contain, as a marker, the 37 kDa 
inactive zymogen of the cathepsin L1 digestive peptidase.  In contrast, our analysis of the 
smaller 120K exosome-like vesicle population suggest that they are shed from the tegument 
of adult fluke. Whilst the 120K EV biogenesis “machinery” is constitutively expressed across 
the intra-mammalian developmental stages of the parasite, the cargo molecules packaged 
within the EVs are highly regulated, most likely to facilitate the parasites migration through 
host tissue and to counteract host immune attack. 
 
Experimental Procedures 
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Experimental Design and Statistical Rationale 
Western blots and fluorogenic assays were performed with at least 2 biological replicates and 
three technical triplicates. For the proteomics study, whole Fasciola EVs were initially 
analysed by LC-MS/MS (two technical replicates). These identifications were subsequently 
mapped to the surface/membrane/lumen of the EVs following analysis of the EV fractions, 
which were run without replicates due to the paucity of parasite material. The aim of this 
experiment was to profile the molecules associated with fluke EVs and no quantitation was 
performed.  
 
Isolation of adult F. hepatica extracellular vesicles 
Adult F. hepatica parasites were obtained from bovine livers from local abattoirs. To prepare 
secretions, adult flukes were thoroughly washed with PBS to void their gut contents and then 
maintained in RPMI-1640 culture medium containing 0.1% glucose, 100 U penicillin and 100 
mg/mL streptomycin (Sigma), at 2 worms/mL for 5 h at 37°C. EVs were purified according 
to the differential centrifugation protocol described by Marcilla et al. (12). Briefly, after the 
incubation period, the parasite culture media was collected and centrifuged at low speed (first 
at 300 x g/10 min, and then at 700 x g/30 min) to remove large debris. The resulting 
supernatant was centrifuged at 15,000 x g for 45 min at 4°C to obtain large vesicles. Culture 
supernatants were then filtered using a 0.2 µm ultrafiltration membrane, and centrifuged at 
120,000 x g/1 h at 4°C to recover smaller vesicles that were subsequently washed with PBS. 
 
Immunoblot analysis of the EVs and secretome 
The protein content of adult fluke soluble secretions and EVs was determined using the BCA 
protein assay kit (Pierce). Equal amounts (5 g) of each sample were run on reducing 
NuPage Novex 4-12 % Bis-Tris gels (Life Technologies), and transferred to nitrocellulose 
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membranes (GE Healthcare) at 120 mA for 45 min. Following transfer, the membranes were 
incubated in blocking solution (TBST: 20 mM Tris–HCl, 150 mM NaCl, 1 % Tween-20, pH 
7.6) containing 5 % skimmed milk for 2 h at room temperature (18-21°C). Blots were probed 
with a 1:15,000 dilution of sheep antiserum raised against recombinant F. hepatica 
peroxiredoxin (FhPrx; 22) or recombinant cathepsin L1 (FhCL1; Dalton, unpublished); a 
1:1000 dilution of rabbit antiserum raised against recombinant helminth defence molecule 
(FhHDM-1; 23) or a 1:5,000 dilution of rabbit antiserum raised against recombinant 
Schistosoma mansoni leucine aminopeptidase which is reactive to F. hepatica leucine 
aminopeptidase (SmLAP; 24, Dalton unpublished) for 2 h at room temperature (18-21°C). 
After washing in TBST (3×10 min), an appropriate alkaline phosphatase-conjugated IgG 
secondary antibody was applied to the membranes for 1 h at room temperature (18-21°C) 
before detection using the BCIP/NBT substrate (Sigma). 
 
Trypsin shaving and sequential extraction of purified F. hepatica EVs 
Peptides from surface-accessible proteins were released by trypsin hydrolysis of EVs isolated 
from adult F. hepatica using our previously described protocol (25). Briefly, sequencing 
grade trypsin (Promega) was added to purified F. hepatica EVs at a final concentration of 50 
µg/ml for 5 min at 37ºC.  The treated EVs were then centrifuged at 100,000 x g for 1 h at 
4°C, and the released peptides recovered from the supernatant.  
 To investigate sub-vesicular protein localization, purified F. hepatica EVs were 
sequentially extracted to identify proteins associated with the EV membrane or those 
contained within the EV lumen. First, the EVs were resuspended in water; the resulting 
osmotic shock causes the EVs to burst and release the soluble contents held within the EV 
lumen. The EV membranes were collected by centrifugation at 100,000 x g for 1 h at 4°C, 
whilst the soluble contents of the EV lumen were recovered in the supernatant. The 
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membrane pellet was sequentially extracted with 0.1M Na2CO3 (pH 11) on ice for 30 min to 
extract peripheral proteins and the sample centrifuged at 100,000 x g for 1 h at 4°C. The final 
pellet was then solubilised in 1 % Triton X-100 / 2% SDS for 15 min at 37°C to produce 
integral membrane protein fractions (26).  
 
Mass spectrometry analysis of EV and secretome fractions 
Proteins in the various EV fractions were reduced with 2 mM DTT in 50 mM NH4HCO3 
(60°C/20 min) and alkylated with 5 mM iodoacetamide (room temperature (18-21°C) in the 
dark/30 min). Samples were then incubated with 100 ng/ µL sequencing grade trypsin 
(Promega) (37°C/overnight). The digestions were stopped by the addition of trifluoroacetic 
acid (TFA) to a final concentration of 0.1% and dried in a vacuum centrifuge. The final 
mixtures were reconstituted with 10 µL of 0.1% TFA before analysis by LC-MS/MS. Five 
microliters of the resulting suspension were delivered to an analytical column (Eksigen C18-
CL NanoLC Column, 3 µm; 75 µm x 15cm) equilibrated in 5% acetonitrile/0.1% formic acid 
(FA). Elution was carried out with a linear gradient of 5-35% buffer B in buffer A for 30min 
(buffer A: 0.1% FA; buffer B: acetonitrile, 0.1% FA) at a flow rate of 300nl/min. Peptides 
were analysed in a nanoESI qQTOF mass spectrometer (5600 TripleTOF, ABSCIEX) 
operating in information-dependent acquisition mode, in which a 0.25-s TOF MS scan from 
350–1250 m/z, was performed, followed by 0.05-s product ion scans from 100–1500 m/z on 
the 50 most intense 2-5 charged ions. Peak list files were generated by Protein Pilot v4.5 
(Applied Biosystems) using default parameters and exported to Mascot v2.4.1 (Matrix 
Science) for database searching.  
 
Database searching 
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All MS/MS samples were analysed using Mascot v2.4.1 (Matrix Science). Mascot was set up 
to search a database comprised of the gene models identified within the F. hepatica genome 
(version 1.0, 101,780 entries; 11) assuming trypsin digestion with 1 missed cleavage 
permitted. The F. hepatica gene model sequences can be accessed through WormBase 
ParaSite (http://parasite.wormbase.org/) under accession PRJEB6687 (genomic read data and 
gene model transcripts).  Mascot was searched with a fragment ion mass tolerance of 0.1 Da 
and a parent ion tolerance of 0.1 Da. Iodoacetamide derivative of cysteine was specified in 
Mascot as a fixed modification. Glu->pyro-Glu of the N-terminus, Gln->pyro-Glu of the N-
terminus, deamidation of asparagine and glutamine and oxidation of methionine were 
specified in Mascot as variable modifications.  
 
Criteria for protein identification 
Scaffold (version Scaffold_4.3.0, Proteome Software Inc.) was used to validate MS/MS 
based peptide and protein identifications. Peptide identifications were accepted if they could 
be established at greater than 95.0% probability by the Peptide Prophet algorithm (27) with 
Scaffold delta-mass correction. Protein identifications were accepted if they could be 
established at greater than 95.0% probability and contained at least 2 identified peptides.  
Protein probabilities were assigned by the Protein Prophet algorithm (28). Proteins that 
contained similar peptides and could not be differentiated based on MS/MS analysis alone 
were grouped to satisfy the principles of parsimony. 
 
Analysis of the F. hepatica transcriptome and gene models 
RNA sequencing and gene expression analysis was carried out for multiple lifecycle stages, 
including metacercariae, NEJ 1, 3 and 24 h post-excystment, juvenile 21-day old and adult 
liver flukes, as described by Cwiklinski et al. (11).  Briefly, Illumina TruSeq RNA libraries 
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were prepared and sequenced, with the resulting RNAseq data being mapped to F. hepatica 
genome scaffolds and gene models.  Differential expression analysis in edgeR was carried out 
for all genes to which at least five Illumina reads across all libraries could be mapped.  
Discovery of F. hepatica genes associated with EV machinery was carried out using BLAST 
analysis against the F. hepatica genome.  Briefly, human proteins, inferred from the literature 
to have roles in exosome biogenesis, cargo sorting or uptake, were used as BLAST queries to 
identify homologs in closely-related trematode species (NCBI; trematoda). Both the human 
proteins and trematode homologs were used as BLAST queries to interrogate the F. hepatica 
genome (NCBI v2.2.29). Each match was manually validated and confirmed using InterPro 
(http://www.ebi.ac.uk/interpro/) which detects the presence of conserved protein domains. 
Expression of these identified genes across the F. hepatica lifecycle was investigated using 
the differential expression analysis of all the gene models identified within the genome.  
Hierarchical clustering using Gene Cluster 3.0 (29) was used to group differentially 
expressed genes by similarity of expression, graphically represented using heat-maps.   
 
Analysis of peptidase activity in EVs  
The soluble contents of F. hepatica EVs recovered following the 15,000 x g and 120,000 x g 
centrifugation of fluke culture media were isolated by osmotic shock. Briefly, the vesicle 
pellets were resuspended in hypotonic buffer (20 mM HEPES-KOH; pH 7.3) and placed on 
ice for 30 min with intermittent vortexing followed by sonication (5 x 20s at 20% power).  
The vesicle membranes were then removed by centrifugation at 20,000 x g for 1 h at 4°C. 
Auto-activation of the native procathepsin L was carried out by incubating the soluble extract 
from the 15,000 x g vesicle pellet (50 µg total protein) at 37C in 100 mM citrate phosphate 
buffer, pH 4.5, containing 1 mM DTT. Aliquots (15 l) were removed at time intervals and 
added to tubes containing 1 l of 1 mM E-64 to stop the reaction. Proteolytic cleavage of the 
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prosegment was visualised by immunoblotting as described above.  Cathepsin L activity was 
also monitored in the presence of the fluorogenic peptide substrate Z-Leu-Arg-NHMec (20 
M) by measuring the release of fluorescence over time using a Polarstar Omega micro-plate 
reader (BMG Labtech) in 96-well fluorescent plates as previously described (30). Cathepsin 
B activity was measured by incubating the soluble vesicular extracts with Z-Arg-Arg-NHMec 
(10 M) in 100 mM citrate-phosphate buffer (pH 6.5) containing 1 mM DTT and 0.01% 
Triton X100. E-64 (10 µM) was used to inhibit cathepsin L and B activity. Leucine 
aminopeptidase activity was measured by incubating the vesicular extracts with the substrate 
H-Leu-NHMec (10 M) in 100 mM Tris-HCl buffer (pH 7.5) containing 1mM MnCl2 and 
0.01% Triton X100. Bestatin (50 M), a broad-spectrum aminopeptidase inhibitor (31) was 
used to demonstrate inhibition of the reaction.  
 
Transmission electron microscopy 
Transmission electron microscopy (TEM) was performed on adult flukes as previously 
described (32). Briefly, adult flukes were fixed for 1 h in 2% double-distilled glutaraldehyde 
(DDG; Agar Scientific) in 0.1 M sodium cacodylate buffer (pH 7.2) containing 3% sucrose at 
4 °C. After washing in buffer, specimens were dehydrated in ethanol and embedded in Agar 
100 resin (Agar Scientific). Ultrathin sections (60–70 nm) were cut on a Reichert Ultracut E 
ultramicrotome and collected on bare 200-mesh nickel grids. For immunogold labelling, 
sections were etched with 10% hydrogen peroxide for 5 min then washed with 20 mM Tris-
HCl buffer (pH 8.2) containing 0.1% bovine serum albumin and 2.5 % Tween 20. Grids were 
incubated in normal goat serum (1:20 dilution in Tris-HCl buffer) for 30 min and then 
transferred to primary antibody diluted to 1:20,000 with 0.1% bovine serum albumin/Tris-
HCl buffer for 12–18 h. Grids were washed in bovine serum albumin/Tris-HCl and then 
incubated with 10 nm gold-conjugated goat anti-sheep IgG (Bio Cell International) for 2 h at 
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room temperature (18-21°C). Grids were then lightly fixed with 2% DDG for 3 min, double 
stained with uranyl acetate and lead citrate and examined in a FEI (Philips) CM100 
transmission electron microscope, operating at 100 keV. Controls included omission of 
primary antibody and incubation of grids with pre-immune serum followed by the secondary 
antiserum.  
 The exosome-like 120K vesicle pellet was analysed by TEM as previously described 
(12). The 15K vesicle pellet was resuspended in PBS and aliquots placed on formvar-coated 
grids and examined in a FEI (Philips) CM100 transmission electron microscope, operating at 
100 keV.  
 
Results 
Profiling the total secretome of adult F. hepatica 
Taking advantage of our recently reported F. hepatica genome and transcriptome datasets for 
the major intra-mammalian life-cycle stages (newly excysted juveniles, NEJs; 21-day old 
immature liver stage juveniles, and adult flukes) (11), we were able to perform a definitive 
characterisation of the secretions of adult F. hepatica. Sixty-nine proteins secreted by adult F. 
hepatica were identified in this analysis (Supplementary Tables 1 and 2). In accordance with 
previous transcriptomic analyses (10,11,33) peptidases were highly represented (12 matches), 
including Pro-Xaa carboxypeptidases, cathepsin L1 and L2 clade members, 
dipeptidylpeptidase III, cathepsin A, legumain 2, metalloendopeptidases and a cathepsin B. 
Inhibitors of serine peptidases, serpin, and cysteine peptidases, cystatin 1, were also 
identified. Another well represented functional group included molecules involved in defence 
against immune effector cells (10 matches), comprising helminth defence molecule (HDM), 
GST-mu and -sigma classes, fatty acid binding protein (FABP Fh 2), thioredoxin and 
thioredoxin-glutathione reductase. Other functional groups included membrane structure (12 
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matches), receptors/transporters (5 matches), enzymes (7 matches), metabolism (6 matches), 
and 14 hits corresponded to proteins with various/unknown functions. A large proportion of 
the identified proteins (30%) possessed a predicted N-terminal signal peptide, including the 
majority of the peptidases. Of the remaining proteins, 57% did not contain a predicted signal 
peptide, whereas 13% could not be predicted due to 5` truncation of the transcripts.  
 
Adult fluke culture supernatants contain distinct sub-populations of EVs 
Following ultra-centrifugation, a homogeneous group of exosome-like EVs (post-120,000 x g 
spin) 30-100 nm in diameter could be isolated from F. hepatica culture media as confirmed 
by transmission electron microscopy (Supplemental Figure 1A, and 12). However, in the 
present study we also recovered a pellet following the 15,000 x g centrifugation step that had 
been previously overlooked. Transmission electron microscopy also revealed that this pellet 
contained membrane-bound vesicles 50-200 nm in diameter (Supplemental Figure 1B-E). We 
performed a protein assay to determine the relative contributions of the 15K pellet, the 120K 
pellet and the final post-120K supernatant to the total protein secreted by adult flukes. We 
determined that adult F. hepatica secretes total protein at a rate of approximately 17.3 
µg/fluke/hr (100%) of which 0.6 µg/fluke/h (3.6%) is associated with the 120K pellet, 1.5 
µg/fluke/hr (8.6%) is associated with the 15K pellet while the majority 15.2 µg/fluke/hr 
(87.8%) remains in solution following the 120K spin. The complexity of each fraction, as 
determined by 1D gel electrophoresis, can be observed in Figure 1A. Each sample is defined 
by a distinct protein profile indicating a compartmentalisation of the total secretome that can 
be separated by centrifugation.  
To investigate these fractions further, each fraction (5 µg total protein) was probed 
with specific antisera available in our laboratory against a range of secreted Fasciola secreted 
molecules (Figure 1B). Immunoblotting showed that bands corresponding to helminth 
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defence molecule (FhHDM; 6 kDa) were detected across all samples with the most intense 
HDM staining observed in the 15K pellet. We found the F. hepatica leucine aminopeptidase 
(FhLAP; 55 kDa) and peroxiredoxin (FhPrx; 24 kDa) in both the 15K and 120K vesicle 
pellets but not in the total secretome or the 120K supernatant.  F. hepatica cathepsin L1 
(FhCL1), which is synthesised as an inactive 37 kDa zymogen (9), was revealed as an intense 
reactive band in the 15K vesicle pellet, but was barely visible by comparison in the 120K 
pellet. While the 37 kDa zymogen was not observed in the total secretome and final 
supernatant, a processed mature 24 kDa cathepsin L containing the catalytic domain was.  
 To confirm the above data, we used fluorogenic peptide substrates to determine the 
relative peptidase activities associated with the vesicle sub-populations (i.e. 15K vs 120K 
pellets). Whilst leucine aminopeptidase activity, measured using the substrate H-Leu-
NHMec, was not detected in soluble extracts from either pellet, strong H-Leu-NHMec 
hydrolysis was observed when the membranes from both the 15K and 120K pellets were 
incubated with the substrate. The activity associated with membranes from the 120K pellet 
was four-fold higher than that associated with the 15K pellet membranes in accordance with 
Acosta et al. (34). In all assays, this leucine aminopeptidase activity was inhibited by 
bestatin, a broad-spectrum aminopeptidase inhibitor (data not shown).  
Equal amounts of total protein from each vesicle sample were incubated with 
diagnostic substrates for cathepsin L (Z-Leu-Arg-NHMec) and cathepsin B (Z-Arg-Arg-
NHMec) activities. Comparison of the hydrolysis of each fluorogenic substrate within the 
linear range of the reactions (15 min) by each extract is shown in Figure 1C. Strong cathepsin 
activity was detected in both 15K and 120K vesicle pellets. However, both cathepsin B- and 
L-specific activity in extracts of the 120K pellet were on average 60% less than that observed 
in extracts of the 15K pellet. In all assays, cathepsin B and L activity were completely 
inhibited by 10 µM E-64, a cysteine peptidase inhibitor (data not shown).  
15 
 
 
The 15K EVs are derived from gastrodermal cells and contain inactive cathepsin L zymogens 
that can be activated at low pH 
Our immunoblot analysis of the centrifugation fractions indicated that adult F. hepatica 
secretes a population of relatively large vesicles (15K pellet) enriched for the inactive 37 kDa 
cathepsin L zymogen (Figure 1B). To determine whether the native zymogen packaged 
within EVs could undergo pH-dependent autocatalytic activation similar to our purified 
recombinant cathepsin Ls (35-37), soluble extracts of the 15K vesicle pellet were incubated at 
low pH (pH 4.5) for up to 3 h at 37°C. Western blot analysis of the in vitro auto-activation 
process shows that the 37 kDa zymogen diminishes over time, concomitant with the 
appearance of a band corresponding to the processed 24 kDa mature enzyme (Figure 2A; 
arrowed). The rate of formation of an active mature enzyme from the inactive zymogen at pH 
4.5 was rapid indicating that autocatalytic activation of the native enzyme occurs readily in 
an acidic environment (Figure 2B). 
 Transmission electron microscopy showed the presence of secretory vesicles densely 
packed within the specialised gastrodermal cells that line the fluke gut (Figure 2C). 
Immunogold labelling using anti-cathepsin L antibodies revealed that these vesicles were 
intensely, and specifically, stained for F. hepatica cathepsin L1 (Figure 2D). No labelling 
was observed in any other structures which indicates that the large vesicles of the 15K pellet 
that are enriched for the 37 kDa cathepsin L1 zymogen originate from the gastrodermal cells 
of the fluke gut.  
 
The proteome of F. hepatica 120K exosome-like EVs  
A proteomics analysis of the small exosome-like EVs (120K vesicle pellet) was performed 
taking advantage of the newly-available genome and transcriptome resources for F. hepatica 
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(11), to gain a deeper coverage of the EV proteome than previously reported (12). Here, we 
performed a sequential treatment to identify differentially located proteins in the EVs. We 
first employed trypsin shaving (25) to release proteins from the surface of the EVs, before 
sequentially extracting them to identify proteins associated with the EV membranes as well 
as soluble proteins packaged within the EV lumen. A total of 180 different EV proteins were 
identified using this approach and their functional annotation is shown in Tables 1 and 2.  
 A number of well-known exosomal markers, including Hsp70, ALIX and members of 
the tetraspanin family, were identified during the proteomics analysis. This supports the 
classification of the vesicles derived from the 120K pellet as “exosome-like”. Peptidases 
were highly represented in the EV proteome. Peptides corresponding to legumain 4/5, 
cathepsin A, cathepsin B6/8 and a Pro-Xaa carboxypeptidase were released following trypsin 
shaving of the EV surface. Other proteases, such as leucine aminopeptidase, various subunits 
of the F. hepatica proteasome and several cathepsin Bs were either found associated with the 
EV membrane (present in carbonate washes), or within the EV lumen (present in the soluble 
extract).  
 Several membrane channels, transporters and other molecules associated with 
membrane structure were identified. These included the ATPase pumps ABCB1/p-
glycoprotein, Na+/K+ ATPase and a phospholipid-transporting ATPase (flippase). Membrane 
transporters such as anoctamin (a calcium-activated chloride channel), Niemann-Pick C1 and 
C2 proteins (cholesterol transporters), an amino acid permease, an inositol transporter and a 
glucose transporter were also found. Other proteins with potential roles in membrane 
structure included various annexins and the F. hepatica T1 tegumental antigen (38). In 
addition to components of the cytoskeleton, peptides corresponding to several metabolic 
enzymes were released following trypsin shaving of the EV surface. These included 
propionyl-CoA carboxylase, glutamate dehydrogenase, glutamine synthase, malic enzyme 
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and malate dehydrogenase and GAPDH while other enzymes were found associated with the 
EV membrane or within the EV lumen. A small number of host-derived proteins were also 
identified including immunoglobulins, casein and acylamino-acid-releasing enzyme 
(Supplemental Table 3). 
 Comparison of our datasets for adult fluke total secretome and the exosome-like EVs 
with the tegumental proteome reported by Wilson et al. (6) revealed that there is an overlap 
in protein expression between these samples (Figure 3A). Of the 180 proteins identified in the 
adult fluke EVs, 35 and 22 proteins were shared with the total secretome and tegument, 
respectively. A total of 9 proteins were shared by the total secretome and tegument, while 
only 9 proteins were found in all three samples. Supplemental Figure 2 shows the 
composition of the total secretome and EV proteome datasets grouped according to function.   
 
Transcriptome profiling reveals that Fasciola EV biogenesis pathways are constitutively 
expressed whilst cargo molecules are developmentally regulated 
A significant number of the proteins identified have roles in the endosomal pathway, or in EV 
biogenesis, and provide insight into the mechanism used by F. hepatica to generate EVs. 
These include various components of the ESCRT-dependent exosome biogenesis pathway 
(e.g. a number of charged multivesicular body proteins, the AAA-ATPase Vps4, IST1, 
syntenin and ALIX), and the ceramide-dependent pathway (e.g. sphingomyelinase). Several 
members of the Rab GTPase family, such as Rab8a, Rab11b and Rab27 that have roles in EV 
biogenesis and release were also found. Also identified were SNAREs (synaptotagmin and 
VAMP7) as well as myoferlin and otoferlin that mediate vesicle trafficking and fusion. A 
cartoon summarising the proteome of the exosome-like EVs from adult fluke is shown in 
Figure 4 and the full mass spectrometry report is shown in Supplementary Table 3. 
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 To gain insight into the putative mechanism(s) of EV biogenesis in F. hepatica we 
conducted an extensive search of the literature for proteins implicated in this process via 
functional studies, largely in mammalian cells. A total of 102 proteins were identified and 
categorised according to their role in vesicle formation including: components of the 
endosomal sorting complexes required for transport (ESCRT) pathway, components of the 
ceramide pathway, roles in EV release (Rabs and SNAREs), RNA/protein/lipid sorting and 
membrane fusion/repair (Supplementary Table 4). These proteins were used as queries to 
interrogate the newly-available F. hepatica genome (11).  All components of the ESCRT 
machinery, except for the charged multivesicular body protein 6 (CHMP6) from the ESCRT-
III complex, were present in the F. hepatica genome. The ESCRT pathway was also well 
represented at the proteome level with up to ten putative members identified during the MS 
analysis of adult fluke exosome-like EVs; most of them were components of the ESCRT-III 
and Vps4 complexes that have roles in multivesicular body (MVB) formation and the final 
membrane budding/abscission steps during the latter stages of EV biogenesis (39).  BLAST 
results also showed that many components of ESCRT-independent pathways for exosome 
release are present in the fluke genome but less widely represented at the proteome level. The 
most significant matches of the MS data include acid sphingomyelinase and tetraspanin 
CD63, that are both involved in exosome biogenesis in mammalian cells.  
 Having identified putative homologs of the EV biogenesis pathway members in F. 
hepatica, we then examined their relative expression levels across the intra-mammalian 
lifecycle stages of F. hepatica. Transcriptome datasets for Fasciola NEJs at 1 h, 3 h and 24 h 
time-points post-excystment were used as well as 21-day old immature liver-stage flukes and 
adult flukes from the bile duct (11). Relative transcript expression levels (fold change on a 
log2 scale) are shown as a heat-map in Figure 5. Taking this broad view, it is apparent that, 
with a few exceptions, putative EV biogenesis pathway members in F. hepatica are 
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constitutively expressed (albeit at low levels), and do not differ greatly in expression levels as 
the parasite migrates from the small intestine, through the liver and into the bile ducts.  
However, when we performed the same analysis of the transcripts encoding the remaining 
proteins identified during our proteomics analysis of adult fluke exosome-like EVs (i.e. those 
not implicated in EV biogenesis and thus termed putative cargo molecules), we found that 
most were expressed at higher levels and were developmentally regulated. As can be seen in 
the heat-map shown in Figure 6, the transcripts can be broadly segregated into two groups: 
(1) those with low levels of expression in the NEJ stage that increase in the 21-day old and 
adult flukes, and (2) those with high levels of expression in the NEJ stage that decrease in the 
21-day old and adult flukes. Group one members included several proteases such as legumain 
4/5, Pro-Xaa carboxypeptidase, cathepsin B4/5/7 and members of cathepsin L clades 1, 2 and 
5. Others included saposin-like and CD59-like proteins, a calcium-binding protein, and a 
range of highly expressed, but uncharacterised, proteins. Notable group two members 
included thioredoxin, peroxiredoxin, cathepsin B2, various proteasome subunits and 
metabolic enzymes such as enolase, malate dehydrogenase and propionyl CoA carboxylase. 
 
Discussion 
The recent availability of new -omics resources for F. hepatica permitted us to conduct the 
most comprehensive analysis of any helminth secretome to date. We have discovered that 
adult F. hepatica secretions are more complex than previously thought, and contain at least 
two sub-populations of EVs that differ according to size, cargo and mechanism of release 
from the parasite. In doing so we have challenged the classic view that soluble proteins are 
the sole mediators of the host-parasite interaction and identified new mechanisms by which 
parasite-derived molecules can interact with host cells. These mechanisms can be classed 
under various headings: (1) Extracellular interaction with host macromolecules. In terms of 
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protein content, soluble molecules made the greatest contribution to the adult fluke total 
secretome (87.8%). This fraction is dominated by members of the cathepsin L cysteine 
peptidase family which represent >80% of the total protein secreted (8-10). Fasciola 
cathepsin Ls perform a variety of roles, mostly associated with extracellular degradation of 
host macromolecules such as collagen to aid parasite migration through host tissues (36,37), 
haemoglobin as a source of nutrition (30) and immunoglobulins to avoid expulsion by the 
host immune system (40). The considerable expenditure devoted to secretion of soluble 
proteins by F. hepatica clearly shows that these tasks are critical for completion of the 
parasite’s life-cycle. (2) Endocytosis of soluble parasite molecules. We have shown that 
cathepsin L1 and helminth defence molecule (HDM), which are both present as soluble 
proteins within F. hepatica secretions, are internalised via the endolysosomal pathway and 
modulate host macrophage function by degradation of toll-like receptor 3 and inhibition of 
vacuolar-ATPase respectively (26,41). The receptors required for uptake of these molecules 
are currently unknown however HDM binds to cholesterol within lipid rafts on the cell 
surface that may initiate internalisation (26). (3) Internalisation of parasite EVs. Although we 
estimate that the 15K and 120K EV pellets hold only 8.6% and 3.6 % of the total protein 
secreted by adult F. hepatica, respectively, they contain potent immunomodulators/virulence 
factors (see below) that would exert greater effects on host cell function than their abundance 
might suggest. EVs secreted by adult flukes will drain, via the bile ducts, into the host gut and 
we have shown that fluke exosome-like EVs are internalised by host intestinal epithelial cells 
(IECs) in vitro (12). While traditionally regarded as a mere physical barrier to infection, IECs 
are now known to express pattern-recognition receptors that enable them to detect a range of 
microbial ligands and transmit signals to underlying gut-associated lymphoid tissues (42). 
Thus, parasite-derived EVs could maintain a systemic Th2/regulatory environment that is 
permissive to fluke survival and reproduction via modulation of IEC immune surveillance.   
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We, and others, have shown that several proteins released by F. hepatica have the 
ability to modulate host immune cell function (43). In this study we have found the majority 
of these immunomodulators are packaged within the exosome-like EVs secreted by adult 
fluke. Whilst F. hepatica peroxiredoxin (Prx) actively drives host Th2 immune responses via 
stimulation of M2 macrophages (44,45), most of the other fluke immunomodulators 
identified so far (despite displaying varied structures and biochemical activities), indirectly 
promote Th2 responses by suppressing the development of Th1/Th17-associated 
inflammation. These include Fasciola helminth defence molecule (HDM), cathepsin L1 
(FhCL1), fatty acid-binding protein (FABP), kunitz-type molecule (Fh-KTM) and Sigma 
class glutathione transferase (GST) (23,41,46-48). The role of F. hepatica Prx in switching 
the host immune response to a Th2 phenotype during the early stages of infection has been 
well documented (44,45). This is in agreement with our transcriptome profiling of EV cargo 
molecules (Group 2, Figure 6). However, our transcriptomics and proteomics profiling 
experiments have shown that the remaining immunomodulators (FhCL1, HDM, FABP, Fh-
KTM and GST sigma) are constitutively expressed across the intra-mammalian life-cycle 
stages of the fluke and are actually up-regulated as the flukes migrate through the liver, enter 
the bile ducts and mature into adult worms (10,11; Group 1, Figure 6). These observations 
suggest that the latter molecules act to maintain the Th2/regulatory phenotype seen during 
chronic infection. Thus, EV cargo molecules, as well as components of the soluble secretome 
of adult F. hepatica (10) are developmentally regulated to facilitate the parasites migration 
through host tissue and to counteract host immune attack. Work is ongoing in our laboratory 
to characterise the EVs secreted by the NEJ stage.  
We have also identified potential immunomodulators not previously thought to be 
secreted by adult F. hepatica, the most notable being members of the cathepsin B family. 
Several cathepsin B transcripts were previously identified in adult flukes, but these enzymes 
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were not detected in the adult fluke secretome and therefore it was suggested that they have 
intracellular house-keeping roles (10). However, we have found that the small exosome-like 
EVs contain at least four developmentally-regulated cathepsin B peptidases. This finding 
establishes that both cathepsin L and B peptidases are secreted by adult flukes, albeit via 
different mechanisms, the former via the gut and the latter via the tegument. Studies in 
Schistosoma mansoni have shown that a cathepsin B, SmCB2, is located in the tegument of 
the adult parasites (49). Also identified, within the EV lumen, were a number of leaderless 
proteins (including Prx, heat shock proteins and annexins) that are homologs of host damage-
associated molecular pattern molecules (DAMPs). DAMPs are leaderless cytosolic proteins 
that are released into the extracellular environment via atypical secretory pathways in 
response to tissue damage (50). They interact with pattern recognition receptors expressed by 
immune cells and thus set off an ‘alarm’ system which often leads to a wound-healing 
scenario (50). Due to their abundance within helminth secretions, we previously speculated 
that DAMP homologs can direct the host immune response (51) and their packaging into EVs 
provides an alternative route for their non-canonical secretion. Whilst the mechanism for 
targeting cytosolic proteins into EVs is not fully understood, ATP-binding cassette (ABC) 
transporters are responsible for packaging some leaderless proteins (e.g. FGF1, IL-1β and 
Hsp70) into EVs destined for secretion (52-54). We identified two ABC transporters 
associated with the F. hepatica EV membrane (ABCB1 and p-glycoprotein 1) that may 
perform similar packaging roles in the parasite.  
The recently-available F. hepatica genome (11) has allowed us, for the first time, to 
identify pathways involved in EV biogenesis in a helminth parasite. Exosomes arise from the 
endosomal system and are formed by inward budding of the multi-vesicular body (MVB) 
membrane that allows capture of cytoplasmic cargo. This step is thought to occur via two 
different routes. Endosomal sorting complexes required for transport (ESCRT) 0, I, II and III, 
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together with syntenin-ALIX complexes, capture ubiquitinated proteins, whilst in the 
ESCRT-independent pathway tetraspanins (e.g. CD63) and various lipid-related enzymes 
(notably sphingomyelinase) can also drive vesicle formation (55,56). The final abscission of 
the budding exosomes into the MVB lumen requires the AAA-ATPase VPS4 (57). The 
exosomes are then secreted into the extracellular space following the fusion of the MVB with 
the plasma membrane, which is dependent on small GTPases including Rab8b, Rab11, 
Rab27a and Rab27b and the Rab effectors otoferlin and synaptotagmin-like protein (58-61). 
We identified F. hepatica homologs of all these key regulators of exosome biogenesis during 
our proteomics analysis of the 120K EV pellet (summarised in Figure 4). However, it is 
significant that whilst the ESCRT pathway was well represented at the proteome level (10 
members were identified in the MS analysis), the only representatives of the lipid-
related/ESCRT-independent pathway were sphingomyelinase and tetraspanin CD63 
(Supplementary Table 4). Based on these findings we propose that exosome biogenesis in 
adult fluke primarily occurs via ESCRT-dependent MVB formation in the tegumental 
syncytium with the exosomes being shed from the apical plasma membrane (although 
functional studies such as RNAi are needed to confirm this). In support of this proposal, 
MVBs have been described during ultrastructural examination of the tegumental syncytia of 
F. hepatica and the related trematode E. caproni (6,12). Furthermore, our comparative 
proteomics analysis revealed that 42% of the proteins identified in the F. hepatica tegumental 
extracts by Wilson et al. (6) were also packaged into the 120K EVs; these contained a variety 
of proteins (e.g. tegumental antigen 1, DM9-containing protein, annexin and tetraspanin) that 
localise primarily within the tegument of F. hepatica and related trematodes (6,38,62-64). 
Determining the specific roles of individual pathway members during exosome biogenesis in 
liver fluke needs further investigation, perhaps by RNAi-mediated gene silencing which is 
functional in this parasite (65). 
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Targeting key regulators of EV biogenesis (including sphingomyelinase, ALIX and 
Rab GTPases) using chemical inhibitors or RNAi has been shown to significantly reduce the 
number of EVs released by mammalian cells. Indeed, supressing EV production to inhibit 
their effect in disease is an emerging therapeutic strategy that has yielded impressive results, 
notably in cancer therapy (reviewed by 14). We have identified F. hepatica homologs of 
several key regulators of EV biogenesis that could be targeted for parasite control if specific 
inhibitors can be found. Although technically challenging, selective inhibition of parasite EV 
biogenesis would prevent the delivery of a range of immunomodulators to host cells and, 
conceivably, tip the host immune balance in favour of Th1-driven parasite elimination. An 
alternative anti-parasite control strategy would be to block the uptake of parasite-derived EVs 
by host cells. Whilst direct fusion of EVs with the plasma membrane of target cells has been 
reported (66), uptake mechanisms akin to receptor-mediated endocytosis (dependent on the 
complement of proteins expressed on the vesicle surface) appear to be the dominant route of 
entry into recipient cells (67). Many of the proteins we identified on the external surface of F. 
hepatica EVs are metabolic enzymes, or other housekeeping proteins, with reported 
“moonlighting” roles in other helminths and microbial pathogens (68). These include malic 
enzyme, enolase, GAPDH, aldolase and annexin which act as parasite adhesion molecules via 
interaction with plasminogen and/or fibronectin on the host cell surface (69-74) and could be 
targets for blocking antibodies. Recently, it was shown that antibodies against O. viverrini 
tetraspanin blocked uptake of parasite EVs by host cholangiocytes, providing proof-of-
concept, at least mechanistically, for this approach as an anti-parasite therapy (75). 
In this report we have performed the first comparative analysis of the soluble and 
vesicular secretions of a helminth parasite. This was made possible by integrating the 
recently-available genome, transcriptome and proteome datasets for this pathogen (11). Our 
study underscores the importance of investigating the role of EVs during acute and chronic 
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fluke infection and presents new opportunities to disrupt EV biogenesis or interaction with 
target cells toward parasite control.  
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Figure 1. Biochemical characterisation of adult F. hepatica EV populations 
A. Typical 1-D profile of the adult F. hepatica total secretome (E/S), the 15K pellet, the 
120K supernatant and 120K pellet. Proteins were separated using NuPage Novex 4-12 % Bis-
Tris gels (Life Technologies), and stained with colloidal Coomassie blue G250.  B. 
Immunoblot analysis of the above fractions using antibodies against F. hepatica 
peroxiredoxin (Prx), cathepsin L1 (CL1), helminth defence molecule (HDM), and S. mansoni 
leucine aminopeptidase (LAP). C. Activity of soluble extracts from the 15K and 120K vesicle 
pellets against a panel of diagnostic fluorescent substrates that measure cathepsin B, 
cathepsin L and leucine aminopeptidase activity.  
 
Figure 2. Gastrodermal cell-derived EVs contain inactive cathepsin L zymogens 
A. Soluble extracts from the 15K vesicle pellet were incubated in 100 mM citrate phosphate 
buffer (pH 4.5) for 3 h at 37°C. Aliquots of the reaction mixtures were removed after 0, 30, 
60, 120 and 180 min and halted with 10 µM E-64 on ice. Samples were then transferred to 
nitrocellulose membranes and probed with an anti-Fasciola cathepsin L1 antibody. The 
inactive zymogen (37 kDa) showed a progressive decrease in intensity concurrent with the 
appearance of a band representing the 24 kDa mature enzyme (arrowhead). B. The auto-
activation of FhCL1 shown in (A) was analysed by following the hydrolysis of the 
fluorogenic dipeptide substrate Z-Leu-Arg-NHMec over 60 min at 37C. The autoactivation 
was inhibited in the presence of 10 µM E-64. C. Transmission electron micrograph (TEM) 
showing secretory vesicles (arrowed) within the specialised gastrodermal cells that line the 
gut of adult F. hepatica. D. TEM showing immunogold labelling for FhCL1 localized to the 
secretory vesicles within a gastrodermal cell within the gut of adult F. hepatica.  
34 
 
Figure 3. Expression of proteins in the tegument, total secretome and EVs of adult F. 
hepatica 
Venn diagram comparing the proteins identified in the total secretome and extracellular 
vesicles (EVs) released by adult F. hepatica (this study), and those found in tegumental 
fractions (tegument) by Wilson et al. (6).   
 
Figure 4. Summary of the proteome of adult F. hepatica exosome-like EVs 
 
Figure 5. Expression of transcripts encoding putative EV biogenesis pathway members 
across the intra-mammalian lifecycle stages of F. hepatica 
Heatmaps are coloured on a log2 scale with up-regulation in red and down-regulation in blue 
relative to metacercariae, depicting log fold change between developmental stages, grouped 
by hierarchical clustering. The F. hepatica life-cycle stages analysed are: newly excysted 
juveniles (NEJ; 1-, 3- and 24-h post-excystment), 21-day old immature liver-stage flukes 
(Juv_21d), and adult flukes from the bile duct.  
 
Figure 6. Expression of transcripts encoding putative EV cargo proteins across the intra-
mammalian life cycle stages of F. hepatica 
Heatmaps are coloured on a log2 scale with up-regulation in red and down-regulation in blue 
relative to metacercariae, depicting log fold change between developmental stages, grouped 
by hierarchical clustering. The F. hepatica life cycle stages analysed are: newly excysted 
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juveniles (NEJ; 1-, 3- and 24-h post-excystment), 21-day old immature liver-stage flukes 
(Juv_21d), and adult flukes from the bile duct.  
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Table 1: Proteins associated with the membrane of EVs from adult F. hepatica. Figures 
represent number of unique peptides 
  Extract 
Protein Identifier Trypsin NaHCO3 TX100/SDS 
     
Proteases & inhibitors     
Legumain 4/5 BN1106_s1861B000097 7 12 0 
Cathepsin B BN1106_s1772B000188 0 13 0 
Cathepsin A BN1106_s1241B000264 3 7 0 
Cathepsin B6/8 BN1106_s793B000177 2 5 0 
Cathepsin B fragment BN1106_s8462B000006 0 4 0 
Cathepsin B4/5/7 BN1106_s13444B000002 0 6 0 
Cathepsin L1 BN1106_s8490B000026 0 5 0 
Lysosomal Pro-X carboxypeptidase BN1106_s1620B000120 0 4 0 
M17 Leucine aminopeptidase 2 BN1106_s617B000566 0 6 0 
20S proteasome subunit alpha 6 BN1106_s1579B000119 0 4 0 
Proteasome beta 1 subunit BN1106_s5855B000168 0 4 0 
Proteasome subunit beta type-5 BN1106_s6770B000051 0 5 0 
Proteasome subunit beta 2 BN1106_s2242B000188 0 5 0 
Proteasome subunit alpha 7 BN1106_s7720B000057 0 3 0 
Proteasome subunit alpha type BN1106_s4981B000066 0 6 0 
Proteasome subunit alpha type BN1106_s3658B000104 0 4 0 
20S proteasome subunit alpha 3 BN1106_s1639B000395 0 2 0 
Lysosomal pro-Xaa carboxypeptidase BN1106_s3518B000132 2 3 0 
Proteasome subunit alpha 6 BN1106_s1259B000205 0 3 0 
M17 Leucine aminopeptidase 1 BN1106_s7079B000034 0 2 0 
20S proteasome subunit beta 2 BN1106_s2284B000154 0 4 0 
Cathepsin L1 BN1106_s10332B000011 0 3 0 
Multicystatin (cys1) BN1106_s1612B000138 0 2 0 
Proteasome subunit alpha type BN1106_s9050B000016 0 2 0 
     
Pumps & transporters     
ABCB1 BN1106_s274B000296 4 2 3 
MDR p-glycoprotein 1 BN1106_s2471B000098 0 0 3 
Glucose-transporter BN1106_s584B000350 0 0 2 
Phospholipid-translocating ATPase IIB BN1106_s435B000242 0 0 3 
ATP synthase subunit alpha BN1106_s4332B000087 0 2 0 
     
Metabolism     
Propionyl-CoA carboxylase alpha BN1106_s1252B000359 17 3 0 
Glutamate dehydrogenase 1 NAD(P)+ BN1106_s5767B000030 5 6 0 
Aldolase BN1106_s4469B000065 2 2 0 
GAPDH BN1106_s5174B000030 5 0 0 
Glutamine synthetase BN1106_s2400B000186 3 3 0 
Propionyl-CoA carboxylase beta BN1106_s1551B000468 0 3 0 
Malic enzyme BN1106_s233B000262 6 0 0 
Hexokinase A BN1106_s175B000200 0 0 2 
Retinol dehydrogenase BN1106_s2277B000049 0 0 2 
Malate dehydrogenase BN1106_s1459B000183 3 0 0 
     
Cytoskeleton     
Actin 5C BN1106_s2907B000133 11 4 0 
Ezrin BN1106_s1300B000145 2 0 2 
Fimbrin BN1106_s1403B000129 7 2 0 
Alpha actinin BN1106_s4069B000247 4 0 0 
Gelsolin BN1106_s2349B000188 3 2 0 
Beta tubulin 1 BN1106_s55B000372 3 0 0 
Rho1 GTPase BN1106_s1908B000177 0 0 2 
     
Chaperones     
Ubiquitin-60S ribosomal protein L40 BN1106_s6576B000103 0 2 2 
Hsp70 BN1106_s309B000234 9 2 3 
Chaperonin containing tcp1 BN1106_s1242B000159 2 0 0 
14-3-3 protein BN1106_s3904B000042 0 0 2 
     
Exosome biogenesis / vesicle trafficking     
Annexin BN1106_s819B000364 8 4 0 
Tetraspanin-CD63 receptor BN1106_s1657B000161 0 5 4 
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Acid sphingomyelinase BN1106_s1285B000159 2 6 0 
Annexin BN1106_s945B000218 2 9 7 
Myoferlin BN1106_s3585B000136 0 0 11 
Tetraspanin-1 BN1106_s915B000136 0 2 2 
ALIX BN1106_s2963B000136 0 0 6 
IST1 BN1106_s3747B000112 2 0 7 
Otoferlin BN1106_s3261B000048 0 0 7 
Vacuolar assembly/sorting protein D1D2-like protein BN1106_s2316B000077 0 0 5 
ALIX BN1106_s1871B000313 0 0 4 
Charged multivesicular body protein BN1106_s2655B000264 0 0 4 
Vacuolar protein sorting-associated protein 4B BN1106_s1437B000141 0 0 4 
Syntenin-1 BN1106_s4740B000062 0 0 3 
Rab8 BN1106_s258B000276 0 0 2 
CD63 antigen BN1106_s4560B000072 0 2 0 
Charged multivesicular body protein 5 BN1106_s6543B000070 0 0 5 
Vacuolar protein sorting 26 BN1106_s1191B000313 0 0 2 
Vacuolar protein sorting-associated protein VTA1 BN1106_s2858B000111 0 0 2 
Annexin B2 BN1106_s500B000161 0 0 2 
     
Antioxidant/Defence     
Peroxiredoxin BN1106_s1614B000280 0 3 2 
Secreted saposin-like protein SAP-3  BN1106_s10326B000017 0 4 0 
Thioredoxin BN1106_s4026B000080 0 3 2 
GST sigma class BN1106_s1081B000242 0 2 0 
     
Carrier proteins     
Major vault protein BN1106_s7273B000042 0 8 0 
Ferritin BN1106_s3950B000041 0 3 5 
Niemann-Pick C2 protein BN1106_s20469B000004 0 2 0 
Ferritin BN1106_s709B000627 0 5 0 
Myoglobin BN1106_s284B000287 0 3 2 
     
Enzymes     
Phosphodiesterase-nucleotide pyrophosphatase BN1106_s1985B000403 0 4 3 
Carbonic anhydrase BN1106_s3009B000044 0 3 3 
Alpha mannosidase BN1106_s666B000200 0 3 0 
Ras-related protein Ral-A BN1106_s637B000246 0 0 2 
Alpha-galactosidase BN1106_s1241B000260 0 2 0 
     
Uncharacterised / other     
F. hepatica tegumental antigen-1 AF153056 6 0 3 
DM9 domain-containing protein BN1106_s5689B000026 2 4 4 
Calmodulin-like protein BN1106_s678B000118 0 2 0 
Uncharacterised BN1106_s3001B000132 0 5 5 
Uncharacterised BN1106_s8038B000016 0 4 7 
Uncharacterised BN1106_s4767B000028 0 2 3 
Uncharacterised BN1106_s6821B000024 0 2 4 
Uncharacterised BN1106_s440B000226 0 0 4 
Uncharacterised BN1106_s1110B000106 0 2 2 
Uncharacterised BN1106_s114B000615 0 2 2 
Uncharacterised BN1106_s4767B000027 0 0 2 
Uncharacterised BN1106_s4413B000122 0 4 0 
Uncharacterised BN1106_s551B000321 0 0 3 
Uncharacterised BN1106_s263B000609 0 4 0 
Uncharacterised BN1106_s3381B000140 0 2 0 
Uncharacterised BN1106_s739B000132 0 0 2 
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Table 2: Top 50 proteins identified within the lumen of EVs released by adult F. hepatica 
Protein ID Identifier Unique Peptides 
   
Proteases   
Legumain 4/5 BN1106_s1861B000097 14 
Cathepsin A BN1106_s1241B000264 11 
Cathepsin B BN1106_s1772B000188 8 
M17 Leucine aminopeptidase 2 BN1106_s617B000566 8 
Cathepsin B6/8 BN1106_s793B000177 7 
Cathepsin L1 BN1106_s8490B000026 7 
20S proteasome subunit alpha 6 BN1106_s1579B000119 7 
Cathepsin B4/5/7 BN1106_s13444B000002 6 
Lysosomal Pro-X carboxypeptidase BN1106_s1620B000120 6 
Proteasome subunit beta type-5 BN1106_s6770B000051 6 
20S proteasome subunit alpha 3 BN1106_s1639B000395 6 
M17 Leucine aminopeptidase 1 BN1106_s7079B000034 5 
   
Membrane structure   
Annexin BN1106_s819B000364 17 
Myoferlin BN1106_s3585B000136 14 
Tetraspanin-CD63 receptor BN1106_s1657B000161 8 
Annexin BN1106_s945B000218 8 
Tetraspanin-1 BN1106_s915B000136 8 
Otoferlin BN1106_s3261B000048 8 
T-cell immunomodulatory protein BN1106_s92B000560 7 
Annexin BN1106_s3266B000046 6 
   
EV biogenesis   
ALIX BN1106_s2963B000136 9 
Acid sphingomyelinase BN1106_s1285B000159 8 
IST1 BN1106_s3747B000112 7 
Vacuolar protein sorting-associated protein 4B BN1106_s1437B000141 7 
ALIX BN1106_s1871B000313 6 
Rab8 BN1106_s258B000276 6 
Rab11b BN1106_s844B000259 6 
   
Channels & transporters   
ABCB1 BN1106_s274B000296 30 
Na+/K+ transporting ATPase subunit alpha BN1106_s521B000167 12 
Niemann-Pick disease type C1 protein BN1106_s1498B000257 10 
MDR p-glycoprotein 1 BN1106_s2471B000098 8 
vATPase subunit I BN1106_s18772B000008 8 
Inositol transporter BN1106_s3611B000052 7 
   
Enzymes   
Phosphodiesterase-nucleotide pyrophosphatase BN1106_s1985B000403 9 
Aldolase BN1106_s4469B000065 9 
Peroxiredoxin BN1106_s1614B000280 5 
Enolase BN1106_s3227B000227 8 
Glutamate dehydrogenase 1 NAD(P)+ BN1106_s5767B000030 7 
Beta-1,4-galactosyltransferase 2 BN1106_s741B000214 6 
   
Uncharacterised/other   
Major vault protein BN1106_s7273B000042 15 
Uncharacterised BN1106_s8038B000016 11 
Actin 5C BN1106_s2907B000133 10 
Uncharacterised BN1106_s3001B000132 9 
DM9 domain-containing protein BN1106_s5689B000026 7 
Uncharacterised BN1106_s216B000184 7 
Uncharacterised BN1106_s6821B000024 6 
Uncharacterised BN1106_s440B000226 6 
Ferritin BN1106_s3950B000041 6 
Ezrin BN1106_s1300B000145 6 
14-3-3 protein BN1106_s3904B000042 5 
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